Dr. Ishan Panchal
My Social Links

Dr. Ishan Panchal

Professor
Arihant School of Pharmacy and Bio-Research Institute, Adalaj, Gujarat, India.


Highest Degree
PostDoc. in Pharmacy from Parul University, Gujarat, India

Share this Profile

Area of Interest:

Area of Interest
100%

Research Publications in Numbers

Books
3
Chapters
0
Articles
27
Abstracts
0

Selected Publications

  1. Patel, A., H. Shah, U. Shah, T. Bambharoliya and M. Patel et al., 2021. A review on the synthetic approach of marinopyrroles: A natural antitumor agent from the ocean. Lett. Org. Chem., 18: 251-264.
    CrossRef  |  Direct Link  |  
  2. Panchal, I., A.G. Devgirkar, A.D. Patel, A. Nagani and C. Lad, 2021. Molecular modelling, synthesis and biological evaluation of novel benzimidazole derivatives for the treatment of breast cancer. Curr. Chin. Chem., 1: 11-20.
    CrossRef  |  Direct Link  |  
  3. Panchal, I.I., R. Rajput and A.D. Patel, 2020. Design, synthesis and pharmacological evalution of 1,3,4-oxadiazole derivatives as collapsin response mediator protein 1 (CRMP 1) inhibitors. Curr. Drug Dis. Technol., 17: 57-67.
    CrossRef  |  Direct Link  |  
  4. Panchal, I.I., S.N. Badeliya, R. Patel, A. Patel and A. Devaligar, 2019. In silico analysis and molecular docking studies of novel 4-amino-3- (isoquinolin-4-yl)-1H-Pyrazolo[3,4-d]pyrimidine derivatives as dual PI3-K/mTOR inhibitors. Curr. Drug Discovery Technol., 16: 297-306.
    CrossRef  |  Direct Link  |  
  5. Panchal, I.I., A. Shah, A. Devgirkar, U. Shah, A. Patel, A. Patel and D.J. Sen, 2019. In silico analysis and molecular docking studies of novel 6,7-dihydropyrano [2,3-d] pyrimidin-5-one derivatives as human epidermal growth factor receptor 2 (HER2) and epidermal growth factor receptor (EGFR) inhibitors. Curr. Cancer Ther. Rev., 15: 235-247.
    CrossRef  |  Direct Link  |  
  6. Patel, A.D., R. Barot, I. Parmar, I. Panchal, U. Shah, M. Patel and B. Mishtry, 2018. Molecular docking, in-silico ADMET study and development of 1,6- dihydropyrimidine derivative as protein tyrosine phosphatase inhibitor: An approach to design and develop antidiabetic agents. Curr. Comput.-Aided Drug Des., 14: 349-362.
    CrossRef  |  Direct Link  |  
  7. Panchal, I.I., D.J. Sen, A.D. Patel, U. Shah, M. Patel, A. Navale and V. Bhavsar, 2018. Molecular docking, synthesis and biological evaluation of sulphonylureas/guanidine derivatives as promising antidiabetic agent. Curr. Drug Discovery Technol., 15: 315-325.
    CrossRef  |  Direct Link  |